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Identification and characterization of prodromal risk syndromes in 
young adolescents in the community: a population-based clinical 
interview study. 
 
Abstract 
While a great deal of research has been conducted on prodromal risk syndromes in relation to help-seeking individuals who 
present to the clinic, there is a lack of research on prodromal risk syndromes in the general population. The current study aimed 
firstly to establish whether prodromal risk syndromes could be detected in non-help seeking community-based adolescents and 
secondly to characterize this group in terms of Axis-1 psychopathology and general functioning. We conducted in-depth clinical 
interviews with a population sample of 212 school-going adolescents in order to assess for prodromal risk syndromes, Axis-1 
psychopathology and global (social/occupational) functioning. Between 0.9% and 8% of the community sample met criteria for a 
risk syndrome, depending on varying disability criteria. The risk syndrome group had a higher prevalence of co-occurring non-
psychotic Axis-1 psychiatric disorders (OR=4.77, CI95=1.81 – 12.52; p<0.01) and poorer global functioning (F=24.5, df=1, 
p<0.0001) compared to controls. Individuals in the community who fulfill criteria for prodromal risk syndromes demonstrate 
strong similarities with clinically-presenting risk syndrome patients not just in terms of psychotic symptom criteria but also in 
terms of co-occurring psychopathology and global functioning. 
 
Introduction 
 
The onset of psychosis is usually preceded by a prodromal 
period prior to full-blown illness. Intervention at this early 
stage offers the hope of disease prevention. The concept of 
prodromal intervention as currently conceived emerged 
from research at the University of Melbourne in the 1990s. 
Yung, McGorry and colleagues developed a set of ‘ultra 
high risk’ (UHR) criteria for help-seeking individuals who 
presented to the clinic, which they demonstrated could 
predict a very high transition rate to psychosis 
(approximately 40%) over a 12-month period. Individuals 
meeting UHR criteria are said to have an ‘at risk mental 
state’ (ARMS). These criteria were used to formulate the 
Comprehensive Assessment of At Risk Mental States 
(CAARMS), a clinical instrument for the assessment of 
ARMS based upon defined criteria involving (i) attenuated 
psychotic symptoms, (ii) frank psychotic symptoms of brief 
duration or (iii) genetic risk combined with functional 
deterioration.
1-3
 Researchers at Yale University developed 
the Structured Interview for Prodromal Syndromes (SIPS) 
with a similar goal and demonstrated that, in line with 
Australian findings, individuals who met criteria for these 
‘prodromal risk syndromes’ were at very high risk for 
psychosis.
4-6
 In Europe, a set of ‘basic symptoms’, such as 
problems in dividing attention, thought blockages and 
disturbances in receptive and expressive language, have 
been used to successfully predict high risk for psychosis, 
either alone or in combination with UHR criteria.
7-10
 The 
largest study to date examining transition from prodromal 
risk syndrome to psychosis has been the collaborative 
North American Prodrome Longitudinal Study (NAPLS), 
which reported that up to 40% of individuals who met risk 
syndrome criteria converted to psychosis over 2.5 years.
6,11
 
 
Such has been the impact of risk syndrome research that a 
new diagnosis – ‘Attenuated Psychosis Syndrome’ – has 
been proposed for the next version of the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-V) (see Figure 
1). The goal of a new diagnosis is to provide a diagnostic 
category that facilitates identification, treatment and 
research. This proposal, however, has sparked a great deal 
of debate amongst leading researchers in the field.
12-18
 One 
important issue is the lack of population studies – while a 
great deal of research has been conducted on psychotic 
symptoms in the general population to date,
19-23
 population 
researchers have not conducted the in-depth clinical 
assessments that have characterized the work of 
researchers at UHR clinics. On the other hand, UHR 
researchers have, to date, focused almost exclusively on 
help-seeking (i.e., self-presenting) individuals, without 
venturing into the community. A more complete 
understanding of prodromal risk syndromes requires that 
the detailed work carried out in UHR clinics be combined 
with a community-based, epidemiological approach. One 
preliminary report that has begun to address this issue 
involved telephone SIPS interviews with a sample of 16 to 
35 year olds from the general population.
24
 The researchers 
reported that just one participant fulfilled criteria for a 
prodromal risk syndrome. However, this study was limited 
by the small sample size (n=58) and the lack of information 
on the validity of telephone interviews compared to face-
to-face assessment. In order to (i) test whether prodromal 
risk syndromes/at risk mental states could be identified 
among young adolescents in the general population and (ii) 
characterize these individuals in terms of psychopathology 
and general functioning, we conducted in-depth 
assessments of psychotic symptomatology among 212 
school-going adolescents aged 11 to 13 years.  
 
Method 
Recruitment 
A sample of 212 adolescents from the general population 
aged 11 to 13 years took part in the current study. They 
were drawn from a sample of 1131 pupils from 16 schools 
in Counties Dublin and Kildare, Ireland, who took part in a 
survey of psychopathology, using the Strengths and 
Difficulties Questionnaire (SDQ),
25
 which is a validated 
instrument that assesses for a wide range of symptoms of 
psychopathology, and for psychotic symptoms, using the 
Adolescent Psychotic Symptom Screener (APSS), which is a 
validated instrument that assesses hallucinations and 
delusions.
26
 Written informed consent was obtained from 
the parent or guardian of participants as well as from the 
participants themselves. Participants of the survey study 
were asked to indicate on the consent form if they would 
consider taking part in a more in-depth study involving a 
clinical interview conducted at the research centre. Of the 
total 1131 adolescents, 656 (58%) indicated an interest in 
taking part in the interview study, from which a random 
sample of 212 were brought to interview.  
 Among the first 20% of the sample who attended for 
interview we enriched at a rate of 2:1 for adolescents with 
a score of 2 or more on the APSS psychotic symptoms 
questionnaire. For the majority (80%), however, the sample 
was a random sample representative of the overall larger 
surveyed sample. A frequency weight was applied in STATA 
for the statistical analyses to account for enrichment at a 
rate of 2:1 in the first 20% of interviewed participants. 
 
Socio-economic status (SES) of each study participant was 
determined using parental occupation assessed according 
to the Irish Social Class Scale from the Irish Central Statistics 
Office. We divided the sample into two major groups 
according to social class: the first group contained SES 
groups 1 and 2 (professional/managerial) and the second 
group contained SES groups 3 to 7: (non-manual skilled; 
skilled manual; semi-skilled manual; unskilled manual; 
unemployed). The SES of participants approximated 
national figures: 34.6% of participants were categorized as 
SES groups 1-2 (compared to 32.1% of the national 
population) and 65.4% as SES groups 3-7 (compared to 
67.9% of the national population). Participants were also 
representative of the overall national ethnic profile from 
the 2006 national census, including 88.9% Irish-born 
participants (compared to 90.3% of 0 to 14 year olds 
nationally). In addition, adolescents who attended for 
interview did not differ from the larger surveyed sample in 
the proportion of abnormal or borderline-abnormal scores 
on the SDQ measure of general psychopathology (x
2
=1.22 
(df=1) p=0.27) or on their score on the APSS measure of 
psychotic symptoms (interviewed group mean=1.8 
(SE=0.12), non-interviewed group mean=1.9 (SE=0.19); 
t=0.26, df=1130, p=0.79).  
 
Interview Assessment 
The principal interview instrument used to assess 
psychopathology in this study was the Schedule for 
Affective Disorders and Schizophrenia for School-aged 
Children, Present and Lifetime Versions (K-SADS).
27
 The K-
SADS is a well-validated semi-structured diagnostic 
interview for the assessment of Axis-1 psychiatric disorders 
in children and adolescents. Adolescents and parents were 
interviewed separately, both answering the same questions 
about the adolescent. The K-SADS includes a psychosis 
section where participants are assessed for psychotic 
symptomatology. This section of the interview was altered 
to include questions covering the five positive symptom 
sections of the SIPS (P1 to P5) in order to provide additional 
information necessary to diagnose prodromal risk 
syndromes. Questions were also added about the onset 
and frequency of and attributions for symptoms, as well as 
questions about whether or not symptoms caused distress 
to the interviewee. The K-SADS interview finished with an 
assessment of the young person’s functioning using the 
Children’s Global Assessment Scale, which is a validated 
measure of global functioning adapted from the Global 
Assessment Scale for adults.
28
 Interviews were conducted 
by two psychiatrists and four psychologists with extensive 
training in the assessment of psychotic symptomatology, 
and involved assessments of between 2 and 4 hours, 
depending on the level of symptoms reported, with 
detailed notes recorded over the course of the interview.  
 
Three certified SIPS raters (IK, AM and MC), trained by a 
senior clinician from the Yale PRIME Prodrome Research 
Clinic (Barbara Walsh), reviewed all interviews and applied 
the criteria of prodromal syndromes (COPS) in order to 
confirm risk syndrome diagnoses. Diagnostic criteria are 
included in Appendix 1 but, briefly, there were 3 possible 
risk syndrome diagnoses. Attenuated positive symptoms 
prodromal syndrome (APSP) is characterized by the 
following: (i) positive psychotic symptoms that are rated as 
three (moderate), four (moderately severe) or five (severe 
but not psychotic) on the P1 to P5 scales, (ii) symptoms 
began, or worsened by one or more scale points, within the 
past 12 months and (iii) symptoms occurred at least one a 
week in the past month. Brief intermittent psychotic 
symptoms prodromal syndrome (BIPS) is characterized by 
the following: (i) positive symptom(s) rated six (i.e., frankly 
psychotic), (ii) symptom(s) have reached a psychotic level of 
intensity within the past three months and (iii) symptom(s) 
have been present for at least several minutes per day at a 
frequency of at least once per month. Genetic risk and 
deterioration prodromal syndrome (GRD) is characterized 
by the following: (i) the participant meets criteria for 
current schizotypal personality disorder or has a first 
degree relative with a psychotic disorder, and (ii) a drop of 
at least 30% in the Global Assessment of Functioning score 
over the past month as compared to 12 months ago. We 
also estimated the prevalence of prodromal risk 
syndromes/at risk mental states according to CAARMS 
criteria (see Appendix 1 for full CAARMS criteria). In 
addition to criteria on positive psychotic symptoms, the 
most recent edition of the CAARMS added a criterion of a 
30% decline in social/occupational functioning. We report 
CAARMS risk syndrome prevalences with and without this 
criterion in our results. 
 
Statistical Analyses 
Statistical analyses were conducted using STATA version 
11.0 for Windows. A frequency weight was applied in 
STATA for the statistical analyses to account for enrichment 
at a rate of 2:1 in the first 20% of interviewed participants 
for adolescents who scored 2 or more on the APSS during 
the survey study. All percentages reported are based on 
weighted data. Chi-square and t-tests were used to 
measure differences in participants who took part in the 
interview study compared to the larger surveyed 
population sample. A prevalence figure is reported for 
prodromal risk syndromes in the interviewed sample. 
Logistic regression was used to examine the relationship 
between risk syndromes and Axis-1 diagnoses. Analysis of 
variance was used to examine the association between risk 
syndrome status and functioning on the Children’s Global 
Assessment Scale. 
 
Ethical approval for this study was granted by the 
Beaumont Hospital Medical Ethics Committee. 
 
Results 
Prodromal risk syndromes/at risk mental states 
A total of 22.6% (n=53) of the sample reported psychotic 
symptoms, primarily auditory hallucinations. Applying SIPS 
criteria, 8.1% (n=19) of the total sample met criteria for a 
current prodromal risk syndrome. Specifically, 7.7% met 
criteria for an attenuated positive symptoms prodromal 
syndrome (APSP) and 3.5% met criteria for a brief 
intermittent psychotic symptoms prodromal syndrome 
(BIPS). One additional participant met criteria for APSP in 
remission. Three participants had a first degree relative 
with a psychotic disorder but none of these participants 
had experienced a significant decline in functioning within 
the past year and so no participant met criteria for GRD. 
There was no significant effect of age or socioeconomic 
status on risk syndrome status. However, significantly more 
males than females fulfilled criteria for a risk syndrome 
(χ
2
=4.17, p=0.04). 
 
Applying the CAARMS criteria, 7.7% of the sample met 
criteria for an at risk mental state without applying a 
criterion of a 30% decrease in functioning in the last year. 
Just 0.9% (n=2) of participants would have met criteria for 
an at risk mental state, however, were a 30% decrease in 
functioning used as an obligate criterion (using the 
Children’s Global Assessment Scale as the measure of 
functioning). 
 
Attenuated Psychosis Syndrome 
The proposed DSM-V diagnosis of attenuated psychosis 
syndrome (see Figure 1) differs from APSP in Criterion D, 
that is, the requirement that, in addition to attenuated 
psychotic symptoms, there is also distress and disability. 
The majority of adolescents who fulfilled criteria for APSP, 
in fact, did report being distressed by their symptoms 
(89%). Similarly, in terms of disability, adolescents who 
fulfilled criteria for APSP also demonstrated significantly 
impaired functioning compared to controls, as measured by 
the Children’s Global Assessment Scale (F=24.5, df=1, 
p<0.0001). 
 
Prodromal Risk Syndromes and Psychiatric Comorbidity 
A total of 63% of the adolescents who met criteria for a 
prodromal risk syndrome also met criteria for at least one 
lifetime Axis-1 diagnosis (OR=4.77, CI95=1.81 – 12.52; 
p<0.01) (see Table 1). The most common lifetime Axis 1 
diagnosis was major depressive disorder (MDD) (26%). 
Thirty seven percent of adolescents with risk syndromes 
met criteria for a depressive disorder, 32% met criteria for 
an anxiety disorder and 21% met criteria for a behavioral 
disorder. Furthermore, 30% reported current or past 
suicidal ideation and 20% reported a history of self harm. 
 
Discussion 
In a general population sample of 212 school-going 
adolescents, we found that up to 8% fulfilled criteria for 
diagnosis of a current prodromal risk syndrome. The 
findings of the current work suggest that there are many 
prospectively identifiable individuals with risk syndromes in 
the community who have not presented to clinical services. 
What proportion of these individuals would ultimately 
present to services is unknown. However, while the 
overwhelming majority of cases of new onset psychosis 
have been established to be preceded by a prodromal 
period,
29-31
 only a minority of the population-wide 
incidence of psychosis emerge in patients from prodrome 
risk syndrome clinics, which suggests that many such 
individuals will not clinically present prior to illness onset. 
 
APSP, as described, differs from the proposed DSM-V 
diagnosis of attenuated psychosis syndrome in Criterion D 
(“distress/disability/treatment seeking”, see Figure 1). 
However, the majority of adolescents meeting criteria for 
APSP reported distress as a result of their symptoms and 
this group demonstrated significantly poorer functioning on 
the Children’s Global Assessment Scale. BIPS diagnoses, 
which usually constitute a relatively small proportion of 
patients seen in prodromal risk syndrome clinics, were 
present in 40% of all risk syndromes in the current study. 
Interestingly, in the clinic, risk for psychosis has been 
demonstrated to be particularly high for patients with BIPS, 
with a faster onset of psychosis compared to young people 
with APSP.
32
 It is possible that fewer BIPS patients will 
present clinically during the prodrome and are more likely 
to present for the first time during first episode psychosis 
due to what appears to be a shorter prodromal period. It is 
also possible that, because the symptoms are ‘brief’ and 
‘intermittent’, that patients believe their symptoms have 
resolved and are, as a result, less likely to seek help. Further 
research will be necessary to understand this difference 
between the clinic and the community.  
 
Non-psychotic psychiatric disorders were present in a large 
majority of adolescents with prodromal risk syndromes, 
consistent with research on clinically-presenting 
individuals.
33
 Rosen et al., for example, reported that in a 
sample of clinically presenting individuals who met criteria 
for a prodromal risk syndrome, 76% had at least one 
diagnosable lifetime Axis 1 disorder.
34
 Svirskis et al., 
similarly, reported that over 90% of help-seeking individuals 
who met criteria for a prodromal risk syndrome had at least 
one comorbid disorder.
35
 Depressive disorders were the 
most common diagnosis in both studies, as in the current 
report. Lencz et al., using the same diagnostic instrument as 
the current study to assess for Axis-1 psychopathology in a 
sample of putatively prodromal help seekers, found MDD 
to be the most common diagnosis, followed by attention 
deficit/hyperactivity disorder, in keeping with our own 
community findings.
36
 
 
There are a number of implications of this research in 
relation to the proposed DSM-V diagnosis of attenuated 
psychosis syndrome. Findings from the current study that 
might support this diagnosis include that (i) a large majority 
of the individuals identified are distressed by their 
symptoms; (ii) this group demonstrates significantly poorer 
global functioning; and (iii) the majority of these 
adolescents have other diagnosable psychopathology that 
suggests that they as a population are truly in need of care. 
On the other hand, the findings of the current study also 
raise a number of concerns or limitations with regard to 
creation of an ‘attenuated psychosis syndrome’ diagnosis, 
including that (i) the proposed diagnostic criteria are 
applicable to a relatively large proportion of adolescents, 
meaning that, following publication of DSM-V, many young 
people could suddenly be imposed with a stigmatizing 
diagnosis that they did not previously have; (ii) we do not 
know the relative risk for psychosis among this group since 
longitudinal community research has not been conducted. 
Given the high prevalence of the syndrome, however, it is 
unlikely to approach the level of risk observed in help-
seeking samples reported on to date; thus, we risk greatly 
increasing the rate of false positives; (iii) since the majority 
of these individuals already have psychiatric disorders, 
there would not, in most cases, appear to be a major 
financial barrier to receiving psychiatric treatment in 
healthcare systems that require a formal diagnosis for 
insurance purposes; (iv) the proportion of adolescents who 
fulfill criteria for a risk syndrome varies greatly depending 
on how ‘disability’ is interpreted in terms of the degree of 
functional decline, something that is not currently specified 
in the proposed criteria; and (v) ‘attenuated psychosis 
syndrome’ may be a misnomer for a syndrome that is, in 
fact, associated with a wide range of (non-psychotic) 
disorders.  
 
It is important to note that none of the participants in the 
current study, despite meeting criteria for prodromal risk 
syndromes, had presented to a prodrome or other 
healthcare clinic and so none of the participants can be 
considered ‘help seekers’ in the same way as individuals 
who have been reported on to date in clinic-based 
research. Why some individuals who meet risk syndrome 
criteria present to clinics while others do not is unclear and 
will require further research. There are many possible 
reasons for this. As already speculated, given the high 
proportion of BIPS in the current community study 
compared to the proportion of BIPS in clinic-based studies, 
it is possible that young people with BIPS are less likely to 
present to the clinic. The young age of participants in the 
current study may also be a contributing factor. Although, 
in our experience, even at this age, young people are very 
aware that these experiences are unusual, it is possible that 
younger individuals are less likely to attend their doctor or 
other health professional compared to older teenagers and 
young adults. Education around psychotic symptoms and 
psychosis risk syndromes may also be a factor. Addington et 
al., for example, showed that, following an extensive 
community education program, referrals to prodrome 
services increased.
37
 Thus, a lack of community education 
and confusion about ‘where to turn for help’ with these 
unusual experiences may play a role in non-presentation. 
There may be multiple other differences between help-
seeking and non-help seeking individuals with prodromal 
risk syndromes. Further cross-sectional and longitudinal 
research comparing clinical and community samples will be 
necessary to address this question.  
 
Strengths and Limitations 
The general population sampling method used in the 
current study is the major strength, which allowed us to 
estimate the population prevalence of prodromal risk 
syndromes/at risk mental states. In addition, the approach 
used in the current study allowed us to investigate 
psychopathology and global functioning in very early stages 
of psychosis risk – earlier even than clinically presenting risk 
syndrome cases. A limitation is that the standard SIPS 
interview instrument was not used; rather the K-SADS 
instrument was altered to include SIPS questions on 
positive symptoms from sections P1 to P5. Thus, it might be 
argued that this could result in underestimation of the true 
prevalence of prodromal risk syndromes. While we 
surveyed a relatively large number of adolescents, a 
relatively small proportion was brought to interview, 
introducing the risk of ascertainment bias, whereby 
individuals with a personal or family history of disorder may 
be more likely to agree to participate, thus self-selecting for 
increased rates of the disorder under study. However, we 
do not believe this to be the case in the current study for a 
number of reasons: (i) adolescents who attended the full 
interview study did not differ from the larger surveyed 
school sample from which they were drawn in terms of 
symptoms of general psychopathology, as measured by the 
SDQ, or in terms of psychotic symptoms, as measured by 
the APSS; (ii) only 1.3% of participants had a first degree 
relative with a history of psychotic illness, suggesting that 
families with psychosis were not more likely to participate; 
and (iii) the prevalence of mental disorders was very similar 
to previous epidemiological work both nationally and 
internationally.
38,39
 Participants were also representative of 
the general population in terms of ethnicity and 
socioeconomic status. Nonetheless, further work to confirm 
our findings will be valuable.  
 
It is important to note that research to date suggests that 
psychotic symptoms are more prevalent in early compared 
to later childhood. In a meta-analysis of population-based 
studies on the prevalence of psychotic symptoms in child 
and adolescent populations, we found that psychotic 
symptoms were more common in younger (ages 9 to 12 
years) compared to older (ages 13 to 18 years) children.
40
 
Thus, research in later adolescence, when psychosis risk is 
highest, might not find an equally high prevalence of 
prodromal risk syndromes compared to the younger 
population assessed in the current study. Further research 
among different age groups is necessary to address this 
question.  
 
Conclusion 
Up to 8% of a community sample of 11 to 13 year olds met 
criteria for a prodromal risk syndrome in the current study. 
Adolescents with risk syndromes demonstrated poorer 
global functioning and high rates of non-psychotic 
psychopathology, consistent with findings on clinically 
presenting risk syndrome patients. The long term outcomes 
for these ‘community risk syndromes’ has yet to be 
determined and will require further research. However, the 
decline in rates of conversion to psychosis at risk syndrome 
clinics over the past number of years highlights the fact 
that, even in clinically presenting individuals, outcomes are 
not clear cut.
33,41
 Follow up research will be necessary to 
determine the degree of risk for clinical psychosis 
associated with prodromal risk syndromes in the 
community. 
 Figure 1: Criteria for the proposed Attenuated Psychosis Syndrome for DSM-V: 
a)      Characteristic symptoms: at least one of the following in attenuated form with intact reality testing, 
but of sufficient severity and/or frequency that it is not discounted or ignored 
(i)               delusions 
(ii)              hallucinations 
(iii)             disorganized speech  
b)     Frequency/Currency: symptoms meeting criterion A must be present in the past month and occur at an 
average frequency of at least once per week in past month  
c)      Progression: symptoms meeting criterion A must have begun in or significantly worsened in the past 
year 
d)     Distress/Disability/Treatment Seeking:  symptoms meeting criterion A are sufficiently distressing and 
disabling to the patient and/or parent/guardian to lead them to seek help 
e)      Symptoms meeting criterion A are not better explained by any DSM-5 diagnosis, including substance-
related disorder 
f)       Clinical criteria for any DSM-V psychotic disorder have never been met 
 
Table 1: Lifetime Axis 1 diagnoses and suicidal behavior in patients with prodromal risk syndromes and in 
controls 
Lifetime Axis 1 diagnosis Prodromal risk syndrome 
(n=19) 
Controls  
(n=193) 
Any diagnosis 63% 28% 
Affective disorders 37% 13% 
Major Depressive Disorder 26% 5% 
Dysthymic disorder 0 0.5% 
Adjustment disorder with depressed 
mood 
16% 8.4% 
Behavioral Disorders 21% 7% 
Attention Deficit/Hyperactivity Disorder 16% 4% 
Oppositional Defiant Disorder 5% 4% 
Conduct Disorder 0 1% 
Anxiety Disorders 16% 13% 
Generalized Anxiety Disorder 0 6% 
Separation anxiety disorder 5% 5% 
Avoidant disorder 5% 2% 
Obsessive Compulsive Disorder 5% 2% 
Social phobia 5% 5% 
Suicidal ideation 30% 5% 
Self-harm  20% 6% 
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 Appendix 
 
Structured Interview for Prodromal Syndromes (SIPS) criteria 
Prodromal syndrome diagnostic categories include: (i) brief intermittent psychotic symptoms prodromal syndrome (BIPS), (ii) 
attenuated positive symptoms prodromal syndrome (APSP) and (iii) genetic risk and deterioration prodromal syndrome (GRD). 
 
1. Brief intermittent psychotic symptoms prodromal syndrome (BIPS) criteria 
1a) At least one of the P1 to P5 scales scored a six (that is, psychotic)  
Plus 
1b) The symptom(s) have reached a psychotic level of intensity within the past three months 
Plus  
1c) The symptom(s) have been present for at least several minutes per day at a frequency of at least once per month 
 
2. Attenuated positive symptoms prodromal syndrome (APSP) criteria  
2a) At least one of the P1 to P5 scales (which relate to positive psychotic symptoms) is scored three (moderate), four (moderately 
severe) or five (severe but not psychotic)  
Plus 
2b) Symptom(s) have begun, or worsened by one or more scale points, within the past 12 months  
Plus  
2c) Symptom(s) have occurred at an average frequency of at least once per week in the past month 
 
  
3. Genetic risk and deterioration prodromal syndrome (GRD) criteria  
3a) The participant meets criteria for current schizotypal personality disorder or has a first degree relative with a psychotic disorder 
plus 
3b) A drop of at least 30% in the Global Assessment of Functioning score over the past month as compared to 12 months ago. 
Note, in the current study, given the complex issues around diagnosing young people (aged 11 – 13 years) with personality 
disorders, a diagnosis of GRD could only be given if, in addition to the stipulated functional decline, the individual had a first degree 
relative with a psychotic disorder. 
 Clinical Assessment of At Risk Mental States (CAARMS) criteria 
Prodromal syndrome diagnostic categories include (i) vulnerability group, (ii) attenuated psychosis group and (iii) brief limited 
intermittent psychotic symptoms (BLIPS group) 
 
1. Vulnerability Group criteria 
1a) Family history of psychosis in a first degree relative or schizotypal personality disorder in the identified patient 
Plus 
1b) 30% drop in social/occupational functioning (measured on the Social and Occupational Functioning Assessment Scale – SOFAS) 
compared to premorbid level, sustained for a month, occurred within past 12 months or a SOFAS score of 50 or less for past 12 
months or longer 
 
2. Attenuated Psychosis Group criteria 
2a) Psychotic symptoms of subthreshold intensity, specifically a global rating scale score of 3-5 on Unusual Thought Content 
subscale, 3-5 on Non-Bizarre Ideas subscale, 3-4 on Perceptual Abnormalities subscale and/or 4-5 on Disorganised Speech subscales 
of the CAARMS  
Plus 
2b) Frequency Scale Score of 3-6 on Unusual Thought Content, Non-Bizarre Ideas, Perceptual Abnormalities and/or Disorganised 
Speech subscales of the CAARMS for at least a week 
2c) Subthreshold frequency: Global Rating Scale score of 6 on Unusual Thought Content, 6 on Non-Bizarre Ideas, 5-6 on Perceptual 
Abnormalities and/or 6 on Disorganised Speech subscales of the CAARMS 
Plus 
2d) Frequency scale score of 3 on Unusual Thought Content, Non-Bizarre Ideas, Perceptual Abnormalities and/or Disorganised 
Speech subscales of CAARMS 
Plus (for both categories) 
2e) Symptoms present in past year 
Plus (for both categories) 
2f) 30% drop in SOFAS score from premorbid level, sustained for a whole month, occurred within past 12 months or SOFAS score of 
50 or less for past 12 months or longer 
 3. BLIPS Group criteria 
3)a Global Rating Scale score of 6 on Unusual Thought Content subscale, 6 on Non-Bizarre Ideas, 5 or 6 on Perceptual Abnormalities 
subscale and/or 6 on Disorganised Speech subscales of the CAARMS 
Plus 
3b) Frequency Scale score of 4-6 on Unusual Thought Content, Non-Bizarre Ideas, Perceptual Abnormalities and/or Disorganised 
Speech subscales 
Plus 
3c) Each episode of symptoms is present for less than one week and symptoms spontaneously remit on every occasion 
Plus 
3d) Symptoms occurred during last year 
Plus 
3e) 30% drop in SOFAS score from premorbid level, sustained for a month, occurred within past 12 months or SOFAS score of 50 or 
less for past 12 months or longer 
 
Note: in the current study the social/occupational functioning measure was the Children’s Global Assessment Scale and not Social 
and Occupational Functioning Assessment Scale. The criterion of a 30% decline in social/occupational functioning was added to the 
most recent edition of the CAARMS but was not a criterion for prodromal syndromes in previously published research. We report 
prevalences for CAARMS prodromal syndromes (i) without and (ii) with this new criterion.  
 
 
